Skip to main content
SpringerLink
Log in

Scale-up needed to meet WHO 2030 HCV target in Malaysia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2018 US dollars

  2. 2018 US dollars

Reference

  • McDonald SA, et al. Projections of the Healthcare Costs and Disease Burden due to Hepatitis C Infection under Different Treatment Policies in Malaysia, 2018-2040. Applied Health Economics and Health Policy : 25 Aug 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0425-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scale-up needed to meet WHO 2030 HCV target in Malaysia. PharmacoEcon Outcomes News 811, 28 (2018). https://doi.org/10.1007/s40274-018-5257-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5257-8

Search

Navigation